Diagnosis of dermatomyositis normally includes the identification of myositis-specific autoantibodies, such as anti-Mu2, anti-MDA5, anti-SAE1 (anti-small ubiquitin-like modifier-1 activating enzyme), or anti-nuclear autoantibodies (87). This evidence concerns the gene IFIH1 and dermatomyositis.